JVIMX | VTTSX | JVIMX / VTTSX | |
Total Expense Ratio | 1.08 | 0.08 | 1,350% |
Annual Report Gross Expense Ratio | 1.46 | 0.08 | 1,825% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 5.364 | 6.927 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 319M | 33.1B | 1% |
Annual Yield % from dividends | 1.29 | 2.03 | 63% |
Returns for 1 year | 9.40 | 11.00 | 85% |
Returns for 3 years | 13.37 | 31.63 | 42% |
Returns for 5 years | 26.34 | 51.20 | 51% |
Returns for 10 years | N/A | 98.40 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBBQ | 21.25 | 0.34 | +1.63% |
Invesco Nasdaq Biotechnology ETF | |||
IWM | 211.90 | 3.37 | +1.62% |
iShares Russell 2000 ETF | |||
GCC | 19.72 | 0.09 | +0.47% |
WisdomTree Enhanced Commodity Stgy Fd | |||
RAVI | 75.21 | 0.03 | +0.04% |
FlexShares Ultra-Short Income ETF | |||
CEMB | 44.67 | -0.09 | -0.20% |
iShares JP Morgan EM Corporate Bond ETF |